Funding news
Spot Biosystems logo

Spot Biosystems Raises $40.0M Funding

Recently funded · $40.0M UnknownHospitals and Health CareView source

Get the full Spot Biosystems company profile

Access contacts, investors, buying signals & more

Open in Dashboard

Pushing the boundaries of gene therapy beyond traditional viral vectors, Spot Biosystems has secured $40.0M in new funding. The biotech firm is developing an extracellular vesicle (EV) delivery platform designed to safely and effectively deliver genetic medicines that viral vectors cannot, while also avoiding issues like immunogenicity and toxicity.

The capital will further advance Spot Biosystems' next-generation non-viral gene therapy, which is capable of serial dosing. Its lead program, targeting Duchenne muscular dystrophy, is already in human trials, showcasing the platform's potential to address complex genetic diseases.

Other recently funded companies

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
GRAIL logo

GRAIL

United States

$7.1B
4
Illumina logo

Illumina

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
Bestie Bite logo

Bestie Bite

$1.7M
2
Dream Cyber Security Ltd. logo

Dream Cyber Security Ltd.

$260.0M
3
Choco Up logo

Choco Up

Singapore

$15.0M
4
vibefam logo

vibefam

Singapore

$1.0M
5
Invisible Narratives | INVIZ logo

Invisible Narratives | INVIZ

United States

$25.0M